Clinical Researcher and Founder and CEO
Dr. Emad Salman Shaikh, MD, MPH
Dr. Shaikh is a visionary physician-executive and clinical research leader with over 16 years of global experience driving innovation in drug development across metabolic, neurological, rare diseases, and oncology. As the Founder & CEO of Crimson Integrated Research (CIR), he combines deep clinical expertise (Harvard MPH, Cornell-trained physician) with strategic drug development leadership, having directed Phase I-IV trials, IND/NDA submissions, and multi-regional regulatory strategies for top biopharma firms, including Takeda, Merck, Vertex Pharmaceuticals, Medtronics, Helix Pharma, and Harvard-affiliated academic institutions.
A pioneer in operational excellence, he has successfully demonstrated reduced trial timelines, optimized budgets and maintained full regulatory compliance across global programs. His work spans adaptive trial design, real-world evidence (RWE), and AI-driven clinical analytics, supported by certifications in biostatistics (Harvard), ICH-GCP compliance, and lifesciences commercialization (RA Capital, Harvard Biotech Club).
Beyond execution, Dr. Shaikh is a mentor and policy leader, having shaped ICH E6, E8, and E17 MRCT guidelines and didactics at Harvard and trained 10+ biopharma teams in risk-based monitoring and decentralized trials. Passionate about equitable research access, he champions diversity in clinical trials and was honored with the AMMP Scholarship for advancing multicultural health initiatives.
Under his leadership, Crimson Integrated Research delivers faster, smarter, quality-driven and ethically rigorous clinical research bridging science, strategy, and patient impact.
Principal Investigator, Crimson Integrated Research CIR,
Dr Majid Atique MD, DABOM.
Dr. Majid Atique is a board-certified physician with over fifteen years of experience in medicine. He is a highly motivated individual who believes in the advancement of clinical care. He supports Dr. Shaikh’s vision and is committed to contributing to high-impact initiatives in the fields of Obesity, Cardiometabolic Disorders, Nephrology, Neurology, Gastroenterology, Immuno-Oncology, Respiratory, and Rare Diseases. The collaborative effort between Dr. Atique and Dr. Shaikh led to the formation of Crimson Integrated Research (CIR), which aims to embed research into routine care, increase trial accessibility, and improve the participation of underserved populations.
Principal Investigator & Consultant, Crimson Integrated Research CIR – San Antonio Division
Dr. Rashid Atique, MD
Dr. Rashid Atique is a board-certified physician with extensive experience in clinical medicine and healthcare systems. As Principal Investigator and Consultant at the San Antonio division of Crimson Integrated Research CIR, Dr. Atique brings a deep commitment to advancing clinical research through innovation and inclusivity. He shares the collective mission of enhancing trial accessibility, improving operational efficiency, and ensuring diverse representation in research. With a strong clinical background and a focus on patient-centered care, Dr. Atique supports therapeutic areas including Internal Medicine, Endocrinology, Cardiology, and Rare Diseases. His leadership continues to foster meaningful collaboration among healthcare providers, patients, and the research community to drive impactful outcomes and improve lives.
Director Crimson Integrated Research CIR,
Dr Sadia Atique MD, MPH
Dr. Sadia Atique is a physician with five years of experience in clinical research and healthcare operations. She brings a visionary approach to transforming the clinical research landscape. Dr. Sadia and Dr. Shaikh share a common mission: to enhance accessibility, efficiency, innovation, and representation in research by bridging the gap between patients, providers, and biopharma stakeholders. Their goal is to accelerate access to innovative therapies while delivering operational excellence and fostering collaboration across the clinical research enterprise.
Business Development and Operations Manager, Crimson Integrated Research CIR,
Syed Zaidi, PMP, CQM
Mr. Syed Zaidi, with a background in healthcare and technology, is a certified Project and Quality Manager with over ten years of experience in business consultation, policy and procedural development. He oversees Crimson’s quality program, ensuring that only accurate, high-quality data is delivered to clients. Mr. Zaidi plays a vital role in expanding Crimson’s market presence, strengthening client relationships, and driving value through strategic, data-driven solutions. He has successfully supported and consulted for a diverse range of public agencies and private enterprises across the nation.